Consumer Goods
Procter & Gamble

University Research
University of Cincinnati

Clean Water
EPA

Beverage
Hofbrauhaus

Nanoscience Clean Room
University of Louisville

Research
Children's Hospital

Global Gas
Meijer

Liquid Nitrogen Cryopreservation
Hoxworth

Pharmaceutical
Amylin

Biotechnology
ViaCell


Amylin
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines.

The company was founded in 1987 on the discovery of a hormone, amylin, produced by the same beta cells of the pancreas that make insulin. Since then, Amylin has built a strong foundation on research and development. Amylin's scientists are primarily focused on investigating the potential utility of new peptide hormone candidates. The company has amassed significant research and clinical expertise in metabolic medicine including the areas of diabetes, obesity and cardiovascular disease.

By "Challenging Science," Amylin challenges conventional thinking to create innovative approaches to the discovery, development and commercialization of novel therapies for metabolic diseases. Amylin's approach and dedication are rooted in the belief that they will be "Changing Lives" for millions of people - not only with the drugs currently in late-stage development, but also with their pipeline of future therapies.

Site Map About Us Products & Services Client Profiles Total Gas Management National Accounts Resources The Wright Stuff Contact Us
(513) 731-2222, or Toll Free: (800) 637-2222

 Wright Brothers, Inc. All rights reserved.